1990
DOI: 10.1016/0006-8993(90)90866-a
|View full text |Cite
|
Sign up to set email alerts
|

Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
39
0

Year Published

1996
1996
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 106 publications
(45 citation statements)
references
References 26 publications
6
39
0
Order By: Relevance
“…These CB ϩ neurons are larger and more intensely stained than the striatal projection neurons and are distributed in both the patch and the matrix compartments (Kiyama et al, 1990;Bennett and Bolam, 1993;Kubota and Kawaguchi, 1993). In our double-labeling experiments we found that a small number of CB ϩ neurons contained NKX2.1 (arrows in Fig.…”
Section: Nkx21 Is Expressed In Most Striatal Interneuronsmentioning
confidence: 51%
“…These CB ϩ neurons are larger and more intensely stained than the striatal projection neurons and are distributed in both the patch and the matrix compartments (Kiyama et al, 1990;Bennett and Bolam, 1993;Kubota and Kawaguchi, 1993). In our double-labeling experiments we found that a small number of CB ϩ neurons contained NKX2.1 (arrows in Fig.…”
Section: Nkx21 Is Expressed In Most Striatal Interneuronsmentioning
confidence: 51%
“…Among the behavioral difficulties patients experience are issues involving executive function, emotionality, reasoning, and motor skills, all of which are mediated by the FC and/or CB functions [64,65]. A reduction in Calb1 gene and/or protein expression has been detected in brains of patients who suffered from an assortment of neurodegenerative diseases [66,67,68], and several neurobehavioral disorders are correlated with decreased size and/or numbers of Purkinje cells [69,70]. Sex differences in these brain regions in normal animals, such as those reported here, could provide clues underlying the etiologies of these diseases.…”
Section: Discussionmentioning
confidence: 99%
“…The polyclonal antibodies used were raised in guinea pigs against synthetic peptide sequences specific for the various subunits as follows: ␣ 2 subunit residues 1-9, ␣ 3 subunit residues 1-15, and ␥ 2 subunit residues 1-29 (Benke et al, 1991;Gao et al, 1993;Benke et al, 1994;Fritschy and Mohler, 1995). Other antibodies used were rabbit polyclonal antibodies against glutamic acid decarboxylase (GAD; K2 Chemicon, Temecula, CA), Calb (Emson, Cambridge, UK;Seto-Ohshima et al, 1988;Kiyama et al, 1990), Calr (SWant, Bellinzona, Switzerland), Parv (SWant), ChAT (SWant), NPY (Sigma, St Louis, MO), goat polyclonal antibody against ChAT (Chemicon) and monoclonal antibodies against Calb (SWant), Parv (Sigma), and Enk (Seralab Ltd., Crawley Down, U.K.). All antibodies were dissolved in immunobuffer consisting of 1% goat serum in PBS with 0.2% Triton-X and 0.4% Thimerosol (Sigma), except for goat anti-ChAT, which was dissolved in PBS with 0.2% Triton-X.…”
Section: Immunohistochemical Proceduresmentioning
confidence: 99%